KLF6 is frequently inactivated in HCC [35] and, when overexpressed in carcinoma-derived cells, interacts with cyclin D to disrupt cyclin/CDK complexes, to redistribute p21 to CDK2, which promotes G1 cell cycle arrest [61]. Here, CDK2 is linked to carcinoma.